Wolf H. Fridman

87.8k citations

529 papers · 57.4k indexed · 25 hit papers · h-index 100

Immunology top 0.01%
Oncology top 0.01%
Molecular Biology top 0.1%
Pulmonary and Respiratory Medicine top 0.05%
Cancer Research top 0.05%

Co-authors: Catherine Sautès‐Fridman Jérôme Galon Franck Pagès Bernhard Mlecnik Amos Kirilovsky Zlatko Trajanoski Marie Tosolini Gabriela Bindea
Topics: Monoclonal and Polyclonal Antibodies Research (181 papers)Immunotherapy and Immune Responses (141 papers)Immune Cell Function and Interaction (138 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Nature Science New England Journal of Medicine
Partner nations: France United States Belgium

In The Last Decade

Wolf H. Fridman

523 papers receiving 56.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

2006 4.8k citations Jérôme Galon, Anne Costes et al. profile →
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

2009 4.6k citations Gabriela Bindea, Bernhard Mlecnik et al. Bioinformatics profile →
The immune contexture in human tumours: impact on clinical outcome

2012 3.5k citations Wolf H. Fridman, Franck Pagès et al. profile →
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

2013 2.9k citations Gabriela Bindea, Bernhard Mlecnik et al. profile →
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

2016 2.2k citations Étienne Becht, Nicolás A. Giraldo et al. profile →
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer

2005 1.6k citations Franck Pagès, Anne Berger et al. profile →
The immune contexture in cancer prognosis and treatment

2017 1.6k citations Wolf H. Fridman, Catherine Sautès‐Fridman et al. profile →
Tertiary lymphoid structures in the era of cancer immunotherapy

2019 1.1k citations Catherine Sautès‐Fridman, Florent Petitprez et al. profile →
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

2011 877 citations Marie Tosolini, Amos Kirilovsky et al. Cancer Research profile →
Immune infiltration in human tumors: a prognostic factor that should not be ignored

2009 805 citations Franck Pagès, Jérôme Galon et al. profile →
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

2011 765 citations Bernhard Mlecnik, Marie Tosolini et al. profile →
Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

2008 742 citations Marie‐Caroline Dieu‐Nosjean, Éric Tartour et al. profile →
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

2009 724 citations Franck Pagès, Amos Kirilovsky et al. profile →
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

2014 598 citations Claire Germain, Samantha Knockaert et al. profile →
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology

2019 569 citations Gregor Sturm, Francesca Finotello et al. Bioinformatics profile →
Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells

2013 500 citations Jérémy Goc, Claire Germain et al. Cancer Research profile →
The clinical role of the TME in solid cancer

2018 487 citations Nicolás A. Giraldo, Yann Vano et al. profile →
Tertiary lymphoid structures in cancer and beyond

2014 432 citations Marie‐Caroline Dieu‐Nosjean, Jérémy Goc et al. profile →
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies

2020 401 citations Florent Petitprez, Aurélien de Reyniès et al. profile →
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

2016 397 citations Étienne Becht, Aurélien de Reyniès et al. Clinical Cancer Research profile →
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

2022 379 citations Wolf H. Fridman, Florent Petitprez et al. profile →
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

2015 356 citations Nicolás A. Giraldo, Étienne Becht et al. Clinical Cancer Research profile →
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

2020 333 citations Wolf H. Fridman et al. profile →
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

2018 315 citations Florent Petitprez, Étienne Becht et al. profile →
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle

2023 137 citations Wolf H. Fridman, Catherine Sautès‐Fridman et al. profile →

Peers

Countries citing papers authored by Wolf H. Fridman

Since Specialization

Citations

This map shows the geographic impact of Wolf H. Fridman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf H. Fridman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf H. Fridman more than expected).

Fields of papers citing papers by Wolf H. Fridman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolf H. Fridman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf H. Fridman. The network helps show where Wolf H. Fridman may publish in the future.

Co-authorship network of co-authors of Wolf H. Fridman

This figure shows the co-authorship network connecting the top 25 collaborators of Wolf H. Fridman. A scholar is included among the top collaborators of Wolf H. Fridman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolf H. Fridman. Wolf H. Fridman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2687MO CONgRAtS: A randomized phase II study of nivolumab±relatlimab in patients with TLS-positive soft-tissue sarcomas 2025 ·Annals of Oncology ·Florent Peyraud,(unknown),(unknown),Jean‐Philippe Guégan,Jean‐Yves Blay,Emmanuelle Bompas,Mariella Spalato Ceruso,Wolf H. Fridman,Catherine Sautès‐Fridman,(unknown),(unknown),(unknown),(unknown)	0
2	Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 2023 ·Nature Communications ·Teresa Noviello,Anna Maria Di Giacomo,Francesca Pia Caruso,Alessia Covre,Roberta Mortarini,Giovanni Scala,(unknown),Sandra Coral,Wolf H. Fridman,Catherine Sautès‐Fridman,Silvia Brich,Giancarlo Pruneri,(unknown),(unknown),(unknown),Davide Bedognetti,Andrea Anichini,Michele Maio,Michele Ceccarelli	18
3	Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncologybreakdown → 2019 ·Bioinformatics ·Gregor Sturm,Francesca Finotello,Florent Petitprez,Jitao David Zhang,Jan Baumbach,Wolf H. Fridman,Markus List,Tatsiana Aneichyk	569
4	Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma 2017 ·Clinical Cancer Research ·Nicolás A. Giraldo,Étienne Becht,Yann Vano,Florent Petitprez,Laetitia Lacroix,Pierre Validire,Rafael Sanchez‐Salas,Alexandre Ingels,Stéphane Oudard,Audrey Moatti,Bénédicte Buttard,Sarah Bourass,Claire Germain,Xavier Cathelineau,Wolf H. Fridman,Catherine Sautès‐Fridman	263
5	Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapybreakdown → 2016 ·Clinical Cancer Research ·Étienne Becht,Aurélien de Reyniès,Nicolás A. Giraldo,Camilla Pilati,Bénédicte Buttard,Laetitia Lacroix,Janick Sèlves,Catherine Sautès‐Fridman,Pierre Laurent‐Puig,Wolf H. Fridman	397
6	Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting 2015 ·Clinical Cancer Research ·Benoit Beuselinck,Sylvie Job,Étienne Becht,Alexandra Karadimou,Virginie Verkarre,Gabrielle Couchy,Nicolás A. Giraldo,Nathalie Rioux‐Leclercq,Vincent Molinié,Mathilde Sibony,Réza Elaidi,(unknown),Jean‐Jacques Patard,Arnaud Méjean,Wolf H. Fridman,Catherine Sautès‐Fridman,Aurélien de Reyniès,Stéphane Oudard,Jessica Zucman‐Rossi	230
7	Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancerbreakdown → 2015 ·Clinical Cancer Research ·Nicolás A. Giraldo,Étienne Becht,Franck Pagès,Georgios Skliris,Virginie Verkarre,Yann Vano,Arnaud Méjean,Nicolas Saint-Aubert,Laetitia Lacroix,Ivo Natario,Audrey Lupo,Marco Alifano,Diane Damotte,Aurélie Cazes,Frédéric Triebel,Gordon J. Freeman,Marie‐Caroline Dieu‐Nosjean,Stéphane Oudard,Wolf H. Fridman,Catherine Sautès‐Fridman	356
8	TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer 2014 ·Cancer Research ·(unknown),Lucile Crozet,Diane Damotte,Kristina Iribarren,Catherine Schramm,Marco Alifano,Audrey Lupo,Julien Cherfils‐Vicini,Jérémy Goc,Sandrine Katsahian,(unknown),Marie‐Caroline Dieu‐Nosjean,Wolf H. Fridman,Catherine Sautès‐Fridman,Isabelle Cremer	88
9	Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cellsbreakdown → 2013 ·Cancer Research ·Jérémy Goc,Claire Germain,Thi Kim Duy Vo-Bourgais,Audrey Lupo,Christophe Klein,Samantha Knockaert,Luc de Chaisemartin,Hanane Ouakrim,Étienne Becht,Marco Alifano,Pierre Validire,Romain Remark,Scott A. Hammond,Isabelle Cremer,Diane Damotte,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	500
10	Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin 2013 ·Clinical Cancer Research ·Romain Remark,Marco Alifano,Isabelle Cremer,Audrey Lupo,Marie‐Caroline Dieu‐Nosjean,Marc Riquet,Lucile Crozet,Hanane Ouakrim,Jérémy Goc,Aurélie Cazes,Jean–François Fléjou,Laure Gibault,Virginie Verkarre,Jean‐François Régnard,(unknown),Stéphane Oudard,Bernhard Mlecnik,Catherine Sautès‐Fridman,Wolf H. Fridman,Diane Damotte	284
11	Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer 2011 ·Cancer Research ·Luc de Chaisemartin,Jérémy Goc,Diane Damotte,Pierre Validire,Pierre Magdeleinat,Marco Alifano,Isabelle Cremer,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	252
12	Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma 2011 ·Cancer Research ·(unknown),Julien Cherfils‐Vicini,Diane Damotte,Lucile Crozet,Vincent Vieillard,Pierre Validire,Pascale André,Marie‐Caroline Dieu‐Nosjean,Marco Alifano,Jean‐François Régnard,Wolf H. Fridman,Catherine Sautès‐Fridman,Isabelle Cremer	381
13	Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancerbreakdown → 2011 ·Cancer Research ·Marie Tosolini,Amos Kirilovsky,Bernhard Mlecnik,Tessa Fredriksen,(unknown),Gabriela Bindea,Anne Berger,Patrick Bruneval,Wolf H. Fridman,Franck Pagès,Jérôme Galon	877
14	Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response 2010 ·Blood ·Riad Abès,Emmanuelle Gélizé,Wolf H. Fridman,Jean‐Luc Teillaud	155
15	Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence 2009 ·Cancer Research ·Matthieu Camus,Marie Tosolini,Bernhard Mlecnik,Franck Pagès,Amos Kirilovsky,Anne Berger,Anne Costes,Gabriela Bindea,Pornpimol Charoentong,Patrick Bruneval,Zlatko Trajanoski,Wolf H. Fridman,Jérôme Galon	226
16	The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer 2008 ·Cancer Research ·Cécile Badoual,Grégory Bouchaud,Nour El Houda Agueznay,Erwan Mortier,Stéphane Hans,Alain Gey,(unknown),Séverine Peyrard,Pierre Laurent‐Puig,P Bruneval,Xavier Sastre,Ariane Plet,Laure Garrigue‐Antar,Françoise Quintin‐Colonna,Wolf H. Fridman,Daniel Brasnu,Yannick Jacques,Éric Tartour	73
17	Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers 2006 ·Clinical Cancer Research ·Cécile Badoual,Stéphane Hans,José Rodriguez,Séverine Peyrard,Christophe Klein,Nour El Houda Agueznay,Véronique Mosseri,O. Laccourreye,Patrick Bruneval,Wolf H. Fridman,Daniel Brasnu,Éric Tartour	481
18	Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells 2002 ·Journal of Clinical Investigation ·Lydie Cassard,Joël F.G. Cohen-Solal,Annie Galinha,Xavier Sastre‐Garau,Claire Mathiot,Jérôme Galon,Thierry Dorval,Alain Bernheim,Wolf H. Fridman,Catherine Sautès‐Fridman	25
19	Generation and Characterization of a Mouse Single-Chain Antibody Fragment Specific for Disialoganglioside (G _D2 ) 1997 ·Hybridoma ·Sandrine Moutel,Stéphane Birklé,Valérie Laurence,J Michon,Wolf H. Fridman,Jacques Aubry,Jean‐Luc Teillaud	10
20	A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays 1997 ·Hybridoma ·Frédéric Vely,Nadège Gruel,Janine Moncuit,Olivier Cochet‐Escartin,Hélène Rouard,(unknown),Jérôme Galon,Catherine Sautès‐Fridman,Wolf H. Fridman,Jean‐Luc Teillaud	35

About Wolf H. Fridman

Wolf H. Fridman is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 529 papers that have together received 57.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (181 papers), Immunotherapy and Immune Responses (141 papers) and Immune Cell Function and Interaction (138 papers). The work is most often cited by research in Immunology (31.2k citations), Oncology (27.6k citations) and Cancer Research (7.0k citations). Wolf H. Fridman has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Catherine Sautès‐Fridman, Jérôme Galon, Franck Pagès, Bernhard Mlecnik, Amos Kirilovsky, Zlatko Trajanoski, Marie Tosolini, Gabriela Bindea, Florent Petitprez and Patrick Bruneval. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact